Director, Moores Comprehensive Cancer Center at UC San Diego
I lead a premier clinical team of experts who seek to provide compassionate, state-of-the-art care for patients who have pancreatic tumors and individuals at higher risk for the disease. I also lead clinical trials and study the molecular processes in pancreatic cancer development, working toward identifying ways to detect cancer early and creating new therapies to improve survival.
I strive to bring what we learn in the lab directly to the bedside to help manage all types of cancer. The past decades have seen several advances in cancer biology and genomics, and I believe that we have a tremendous opportunity—and an obligation—to channel this progress to impact patients.
I have published more than 200 studies in leading peer-reviewed journals and have been a NIH-funded investigator since 1998. I have served as the chair of the scientific and medical advisory board of the Pancreatic Cancer Action Network and a member of the scientific advisory board for Let’s Win (Sharing Science Solutions for Pancreatic Cancer). I have previously served as the president of the Society of University Surgeons and the American Pancreatic Association. I am a member of the Institute of Medicine of the National Academy of Sciences and the National Cancer Institute’s Pancreatic Cancer Task Force. I am currently serving as the principal investigator and lead of Precision Promise, an exciting new national clinical trials consortium focused on next-generation clinical trials for people who have pancreatic cancer. I also am the international PI of the PRECEDE Consortium, a world-wide effort to make advances in the early detection and prevention of pancreatic cancer.
Lidong Wang, PhD
Associate Director, Pancreatic Cancer Program
After graduating from Peking Normal University with both a M.S and PhD, I did my postdoctoral fellow training in Dr. T. Yamada's laboratory in the Department of Internal Medicine at the University of Michigan. My postdoctoral projects focused on the regulatory mechanism of brain-gut peptide release. Later, I joined the research laboratory of Dr. John Del Valle in the Department of Internal Medicine at the University of Michigan. While working with Dr. Del Valle, I was a lead author on the publications that describe the molecular basis of the structure and function of the G protein coupled receptor. I have been working in the Simeone laboratory for the past 13 years and have focused on studies defining the oncogenic role of ATDC in human cancers.
Jessica Everett, MS, CGC
Senior Director of Research Strategy
After graduating from Peking Normal University with both a M.S and PhD, I did my postdoctoral fellow training in Dr. T. Yamada's laboratory in the Department of Internal Medicine at the University of Michigan. My postdoctoral projects focused on the regulatory mechanism of brain-gut peptide release. Later, I joined the research laboratory of Dr. John Del Valle in the Department of Internal Medicine at the University of Michigan. While working with Dr. Del Valle, I was a lead author on the publications that describe the molecular basis of the structure and function of the G protein coupled receptor. I have been working in the Simeone laboratory for the past 13 years and have focused on studies defining the oncogenic role of ATDC in human cancers.